Healthy Start Reauthorization Act of 2026
Summary
The Healthy Start Reauthorization Act of 2026 (S. 3799) was reported favorably out of the Senate HELP Committee on June 17, 2026, and awaits floor action. It authorizes $145 million annually for FY2026-2030 for the Healthy Start Initiative, a maternal and child health grant program. This is an authorization, not an appropriation, and the direct financial impact on publicly traded healthcare companies is negligible.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.The bill authorizes $145M/year for the Healthy Start Initiative, a maternal health grant program.
- 2.It is an authorization, not an appropriation; actual funding requires a separate spending bill.
- 3.No publicly traded healthcare companies are directly impacted by this legislation.
Market Implications
No market implications. The bill is a routine reauthorization of a federal grant program that does not create new procurement, tax credits, or regulatory changes for any public company.
Full Analysis
- What happened and its current status: On June 17, 2026, the Senate Committee on Health, Education, Labor, and Pensions ordered S. 3799, the Healthy Start Reauthorization Act of 2026, to be reported favorably with an amendment. The bill was introduced on February 5, 2026, by Senator Roger Marshall (R-KS) with three cosponsors. It is now awaiting floor action in the Senate. 2) The money trail: The bill amends Section 330H(e)(1) of the Public Health Service Act to authorize $145,000,000 per year for fiscal years 2026 through 2030 for the Healthy Start Initiative. This is an authorization of appropriations, meaning it sets a spending ceiling but does not actually allocate funds. Actual funding requires a separate appropriations bill. 3) Structural winners and losers: The Healthy Start Initiative provides grants to community-based organizations to reduce infant mortality and improve maternal and child health. No publicly traded companies are directly named or affected. The program funds local health departments, non-profits, and community health centers. 4) Timeline: The bill must pass the full Senate and House and be signed by the President to become law. Given its narrow scope and authorization-only nature, it is low-impact for public equity markets.
Key Legislators
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
DELL FEDERAL SYSTEMS L.P: $1.0B Department of Veterans Affairs Contract
OPTUM PUBLIC SECTOR SOLUTIONS, INC.: $641M Department of Veterans Affairs Contract
OPTUM PUBLIC SECTOR SOLUTIONS, INC.: $773M Department of Veterans Affairs Contract
OPTUM PUBLIC SECTOR SOLUTIONS, INC.: $598M Department of Veterans Affairs Contract
Executive Order: Promoting Efficiency, Accountability, and Performance in Federal Contracting
Executive Order: Accelerating Medical Treatments for Serious Mental Illness
ADVANCED TECHNOLOGY INTERNATIONAL: $304M Department of Health and Human Services Contract
Executive Order: Realigning United States Core Childhood Vaccine Recommendations with Best Practices from Peer, Developed Countries
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Implementing Schedule Policy/Career in the Excepted Service
This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.
Realigning United States Core Childhood Vaccine Recommendations with Best Practices from Peer, Developed Countries
This executive order directs the CDC and ACIP to review and potentially update the U.S. childhood vaccine schedule to align with recommendations from peer developed countries, which recommend fewer vaccines. It maintains insurance coverage for all currently available vaccines without cost sharing and emphasizes protecting religious liberty and parental authority.
Promoting Efficiency, Accountability, and Performance in Federal Contracting
This executive order mandates that federal agencies default to using fixed-price contracts for procurement, shifting away from cost-reimbursement models. It requires written justification and senior-level approval for any non-fixed-price contract over certain dollar thresholds (e.g., $10M for most agencies, $100M for the Department of War), and directs agencies to review and renegotiate their 10 largest non-fixed-price contracts within 90 days. The order also tasks OMB with implementation guidance and the Federal Acquisition Regulatory Council with proposing regulatory amendments within 120 days.